Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
Viridian Therapeutics price target raised to $44 from $35 at RBC Capital
Premium
The Fly
Viridian Therapeutics price target raised to $44 from $35 at RBC Capital
2M ago
Oracle reports Q1 beat, EU says Apple must pay: Morning Buzz
PremiumThe FlyOracle reports Q1 beat, EU says Apple must pay: Morning Buzz
2M ago
Viridian TED data adds new overhang to Amgen’s Tepezza growth, says Barclays
Premium
The Fly
Viridian TED data adds new overhang to Amgen’s Tepezza growth, says Barclays
2M ago
Viridian poised to take share in TED market, says H.C. Wainwright
Premium
The Fly
Viridian poised to take share in TED market, says H.C. Wainwright
2M ago
Viridian Therapeutics price target lowered to $28 from $31 at Oppenheimer
PremiumThe FlyViridian Therapeutics price target lowered to $28 from $31 at Oppenheimer
3M ago
Viridian Therapeutics reports Q2 EPS ($1.02) vs. ($1.27) last year
Premium
The Fly
Viridian Therapeutics reports Q2 EPS ($1.02) vs. ($1.27) last year
3M ago
VRDN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
VRDN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100